• FirefoxInstall the new Firefox »
  •  Dow Down0.45% Nasdaq Down0.49%

    Orexigen Therapeutics, Inc. (OREX)

    -NasdaqGS
    5.64 Down 0.23(3.92%) Feb 27, 4:00PM EST
    |After Hours : 5.65 Up 0.01 (0.09%) Feb 27, 4:32PM EST
    Add to Portfolio
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):1.6
    Mean Recommendation (last week):1.7
    Change:-0.1

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:10.71
    Median Target:10.00
    High Target:16.00
    Low Target:8.00
    No. of Brokers:7

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Jan 23, 2015RBC Capital MktsInitiated Outperform
    Jan 10, 2014WallachBethInitiated Buy
    Oct 3, 2013CowenInitiated Outperform
    Feb 1, 2011JMP SecuritiesDowngradeMkt OutperformMkt Perform
    Feb 1, 2011Canaccord GenuityDowngradeBuyHold
    Dec 3, 2010Rodman & RenshawDowngradeMkt PerformMkt Underperform
    Jul 16, 2010Rodman & RenshawDowngradeMkt OutperformMkt Perform
    Feb 2, 2010Jefferies & CoInitiated Buy
    Jun 24, 2009Rodman & RenshawInitiated Mkt Outperform
    Apr 3, 2008Cowen & CoInitiated Outperform

    More Upgrades & Downgrades for OREX

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy2222
    Buy5444
    Hold0000
    Underperform0000
    Sell0000

    Data provided by Thomson/First Call


    Currency in USD.